Acrs Stock Analysis Aclaris Therapeutics Inc Biotech Stock Gains 1.45 Percent At 4.2 Dollars 20260403 1 Arson Attack on Ebola Treatment Center in Congo Highlights Heightened Health Security Risks MRDN Q1 2026 Earnings Massive EPS Beat Overshadowed by Steep Stock Decline MNST Q1 2026 Earnings EPS Surpasses Estimates as Stock Ticks Lower RBC Capital Flags Potential Q1 Upside for Snowflake Amid Strong Cortex Code Adoption and Steady Product Revenue Growth GAINI Q1 2026 Earnings EPS Misses Estimates Amid Stable Operations Orion Energy Systems Q1 2026 Earnings Surprise Profit Beat Turns Heads WLKP Q1 2026 Earnings EPS Misses Estimates Amid Stable Distribution Units Edge Higher